Optics News

RightEye LLC has announced the availability of its extensive database of more than 1 billion eye-tracking data points from more than 100,000 patient tests conducted using the RightEye system.

NEW YORK – The Neurolens Office design combined with the contoured prism gives clinicians “the ability to solve many issues and symptoms our patients are having,” David Geffen, OD, said here at Vision Expo East.

Orasis Pharmaceuticals recently announced the beginning of a phase 2b U.S. clinical trial to evaluate CSF-1, its presbyopia-correcting eye drop.

by Paul Hrkal, ND

NEW YORK – Patients with trigeminal dysphoria, a condition that prevents the two eyes from working together and results in headache, eye strain and dry eye, are finding relief with spectacle lenses from Neurolens, according to co-inventor Jeffrey P. Krall, OD, here at Vision Expo East.

NEW YORK – RightEye’s Functional Vision EyeQ test offers optometrists the opportunity to objectively test the way the eye moves, whether the eyes are teaming together and if they’re doing so accurately in 4.5 minutes.

NEW YORK – Myopia is a disease, not a refractive error, and it is at epidemic proportions, Pam Lowe, OD, said here at Vision Expo East.

NEW YORK – Essilor of America launched two major products in the categories of refraction and photochromic lenses at a press conference held here during Vision Expo East.

Presbyopic LASIK with micromonovision and aspheric aberration patterns was proven safe and effective in a study, with no reduction of stereopsis and good quality of vision.

Data analysis of a large survey suggests that Americans have experienced less difficulty affording eyeglasses since 2014, possibly due to the economic recovery and health care reform. However, some gender and racial differences persist.